2Litvan I, Bhatia KP, Burn DJ,et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord, 2003,18:467-486.
3Litvan I. Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep,2004 ,4 :296-302.
4Golbe LI. Progressive supranuclear palsy in the molecular age. Lancet, 2000,356 : 870 -871.
5Bohlhalter S, Kaegi G. Parkinsonism: heterogeneity of a common neurological syndrome. Swiss Med Wkly, 2011,141 :w13293.
6Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci ,2003,21:57-60.
7Adams R, Victor M, Ropper AH, et al. Principles of neurology. 6th ed. New York: McGraw Hill, 1997: 1076-1078.
8Lozza C, Baron JC, Eidelberg D, et al. Executive processes in Parkinson' s disease: FDG-PET and network analysis. Hum Brain Mapp, 2004,22:236-245.
9Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage, 2005, 26:912-921.
10Eckert T, Tang C, Ma Y, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord ,2008,23:727-733.
